Pfizer — Spot On Michigan

Ludington Daily News

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with...

West Michigan • May 15, 2019

Ludington Daily News

U.S. FDA Approves VYNDAQEL and VYNDAMAX for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease

West Michigan • May 6, 2019

DetroitNews Business

Pfizer 1Q profit jumps 9% on higher drug sales, lower costs

Michigan Business • May 1, 2019

Ludington Daily News

PFIZER REPORTS FIRST-QUARTER 2019 RESULTS

West Michigan • Apr 30, 2019

WXMI 17 Fox Traverse City

ThermaCare back pain heat wraps recalled due to possibility of burns

Northwest Michigan • Apr 29, 2019

Ludington Daily News

ViiV Healthcare Submits New Drug Application to US FDA for the First Monthly, Injectable, Two-Drug Regimen of Cabotegravir and Rilpivirine for Treatment of HIV

West Michigan • Apr 29, 2019

WWMT Kalamazoo

Pfizer recalls heat wraps that could cause burns

Southwest Michigan • Apr 26, 2019

Ludington Daily News

Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer

West Michigan • Apr 26, 2019

Ludington Daily News

Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis

West Michigan • Apr 18, 2019

Ludington Daily News

Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders

West Michigan • Apr 18, 2019

Ludington Daily News

Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive...

West Michigan • Apr 13, 2019

Ludington Daily News

U.S. FDA Approves IBRANCE (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

West Michigan • Apr 4, 2019

Ludington Daily News

VIZIMPRO (dacomitinib) Receives Marketing Authorization in European Union (EU) for the First-Line Treatment of Adult Patients with EGFR-Mutated Non-Small Cell...

West Michigan • Apr 3, 2019

Ludington Daily News

Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy

West Michigan • Apr 2, 2019

The News Herald | Southgate

How to find a great part-time job in retirement and the benefits of working again

Detroit Metro • Mar 19, 2019

Ludington Daily News

AUGUSTUS Demonstrates Favorable Safety Results of Eliquis Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome...

West Michigan • Mar 17, 2019

Ludington Daily News

U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1

West Michigan • Mar 12, 2019

Ludington Daily News

Pfizer Prices $5,000,000,000 Debt Offering

West Michigan • Mar 5, 2019

Ludington Daily News

Pfizer Receives Positive CHMP Opinion for LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer

West Michigan • Mar 1, 2019

Ludington Daily News

Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials

West Michigan • Feb 19, 2019

Ludington Daily News

Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*

West Michigan • Feb 19, 2019

Ludington Daily News

Phase 3 ARCHES Trial Shows XTANDI (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate...

West Michigan • Feb 11, 2019

White Lake Beacon | Whitehall

Pfizer: 4Q Earnings Snapshot

West Michigan • Jan 29, 2019

DetroitNews Business

Merck, Pfizer were Dow's best, but 2019 looks shakier

Michigan Business • Dec 31, 2018